890
Views
6
CrossRef citations to date
0
Altmetric
Articles

Casting Protocols Following BoNT-A Injections to Treat Spastic Hypertonia of the Triceps Surae in Children with Cerebral Palsy and Equinus Gait: A Randomized Controlled Trial

, , , &
Pages 77-93 | Received 14 Apr 2017, Accepted 15 Apr 2018, Published online: 17 May 2018

References

  • Ackman, J., Russman, B., Thomas, S., Buckon, C., Sussman, M., Masso, P., … Aiona, M. (2005). Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Developmental Medicine and Child Neurology, 47(9), 620–627. doi: 10.1017/S0012162205001222
  • Behnam, A. (2013). Part V Muscle layers and injection points atlas. In K. Alter, M. Hallett, B. Karp, & C. Lungu (Eds.), Ultrasound-guided chemodenervation procedures (pp. 402–403). New York: Demos Medical Publishing.
  • Bjornson, K., Hays, R., Graubert, C., Price, R., Won, F., McLaughlin, J., … Cohen, M. (2007). Botulinum toxin for spasticity in children with cerebral palsy: A comprehensive evaluation. Pediatrics, 120(1), 49–58. doi: 10.1542/peds.2007-0016
  • Blackmore, A. M., Boettcher Hunt, E., Jordan, M., & Chan, M. D. Y. (2007). A systematic review of the effects of casting on equinus in children with cerebral palsy: An evidence report of the AACPDM. Developmental Medicine and Child Neurology, 49(10), 781–790. doi: 10.1111/j.1469-8749.2007.00781.x
  • Bohannon, R. W., & Smith, M. B. (1987). Interrater reliability of a modified ashworth scale of muscle spasticity. Physical Therapy, 67(2), 206–207.
  • Booth, M., Yates, C., Edgar, T., & Bandy, W. (2003). Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatric Physical Therapy, 15(4), 216–220. doi: 10.1097/01.PEP.0000096382.65499.E2
  • Bottos, M., Benedetti, M. G., Salucci, P., Gasparroni, V., & Giannini, S. (2003). Botulinum toxin with and without casting in ambulant children with spastic diplegia: A clinical and functional assessment. Developmental Medicine and Child Neurology, 45(11), 758–762. doi: 10.1111/j.1469-8749.2003.tb00885.x
  • Boyd, R. N., & Hays, R. M. (2001). Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: An ICIDH-2 approach. European Journal of Neurology, 8(Suppl 5), 167–177. doi: 10.1046/j.1468-1331.2001.00049.x
  • Boyd, R. N., Pliatsios, V., Starr, R., Wolfe, R., & Graham, H. K. (2000). Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Developmental Medicine and Child Neurology, 42(1), 32–41. doi: 10.1017/S0012162200000074
  • Clopton, N., Dutton, J., Featherston, T., Grigsby, A., Mobley, J., & Melvin, J. (2005). Interrater and intrarater reliability of the modified ashworth scale in children with hypertonia. Pediatric Physical Therapy, 17(4), 268–274. doi: 10.1097/01.pep.0000186509.41238.1a
  • Cusick, B. (1990). Progressive casting and splinting for lower extremity deformities in children with neuromotor dysfunction. Tucson, Arizona: Therapy Skill Builders.
  • Davis, E., Davies, B., Wolfe, R., Raadsveld, R., Heine, B., Thomason, P., … Graham, H. K. (2009). A randomized controlled trial of the impact of therapeutic horse riding on the quality of life, health, and function of children with cerebral palsy. Developmental Medicine and Child Neurology, 51(2), 111–119. discussion 88. doi: 10.1111/j.1469-8749.2008.03245.x
  • Desloovere, K., Molenaers, G., Jonkers, I., De Cat, J., De Borre, L., Nijs, J., … De Cock, P. (2001). A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. European Journal of Neurology, 8(Suppl 5), 75–87. doi: 10.1046/j.1468-1331.2001.00040.x
  • Feldman, A. B., Haley, S. M., & Coryell, J. (1990). Concurrent and construct validity of the pediatric evaluation of disability inventory. Physical Therapy, 70(10), 602–610.
  • Flett, P. J., Stern, L. M., Waddy, H., Connell, T. M., Seeger, J. D., & Gibson, S. K. (1999). Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. Journal of Paediatrics and Child Health, 35(1), 71–77. doi: 10.1046/j.1440-1754.1999.00330.x
  • Fosang, A., Galea, M., McCoy, A., Reddihough, D., & Story, I. (2003). Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Developmental Medicine and Child Neurology, 45(10), 664–670. doi: 10.1111/j.1469-8749.2003.tb00868.x
  • Glanzman, A., Kim, H., Swaminathan, K., & Beck, T. (2004). Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: A retrospective analysis. Developmental Medicine and Child Neurology, 46(12), 807–811. doi: 10.1111/j.1469-8749.2004.tb00445.x
  • Goldstein, M., & Harper, D. C. (2001). Management of cerebral palsy: Equinus gait. Developmental Medicine and Child Neurology, 43(8), 563–569. doi: 10.1017/S0012162201001025
  • Haley, S., Coster, W., Ludlow, L., Haltiwanger, J., & Andrellous, P. (1992). Pediatric evaluations of disability inventory: Development, standardization and administration manual (1st Ed.). Boston: PD Research Group, Bosotn University.
  • Hanna, S., Bartlett, D., Rivard, L., & Russell, D. (2008). Reference curves for the gross motor function measure: Percentiles for clinical description and tracking over time among children with cerebral palsy. Physical Therapy, 88(5), 596–607. doi: 10.2522/ptj.20070314
  • Hayek, S., Gershon, A., Wientroub, S., & Yizhar, Z. (2010). The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy. The Journal of Bone and Joint Surgery.British Volume, 92(8), 1152–1159. doi: 10.1302/0301-620X.92B8.23086
  • Hedges, L. V. (1981). Distribution theory for glass's estimator of effect size and related estimators. Journal of Educational and Behavioral Statistics, (6), 107–128.
  • Iyer, L., Haley, S., Watkins, M., & Dumas, H. (2003). Establishing minimal clinically important differences for scores on the pediatric evaluation of disability inventory for inpatient rehabilitation. Physical Therapy, 83(10), 888–898.
  • Kay, R., Rethlefsen, S., Fern Buneo, A., Wren, T. A. L., & Skaggs, D. (2004). Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. JBJS the Journal of Bone & Joint Surgery, 86-A(11), 2377–2384.
  • Kelly, B., MacKay Lyons, M., Berryman, S., Hyndman, J., & Wood, E. (2008). Assessment protocol for serial casting after botulinum toxin a injections to treat equinus gait. Pediatric Physical Therapy, 20(3), 233–241. doi: 10.1097/PEP.0b013e3181825c1b
  • Lee, S., Sung, I., Jang, D., Yi, J., Lee, J., & Ryu, J. (2011). The effect and complication of botulinum toxin type a injection with serial casting for the treatment of spastic equinus foot. Annals of Rehabilitation Medicine, 35(3), 344–353. doi: 10.5535/arm.2011.35.3.344
  • Mackey, A., Walt, S., & Stott, N. (2003). Botulinum toxin type A in ambulant children with cerebral palsy;review. Physiotherapy, 89(4), 219–232.
  • McDonough, A. L., Batavia, M., Chen, F. C., Kwon, S., & Ziai, J. (2001). The validity and reliability of the GAITRite system's measurements: A preliminary evaluation. Archives of Physical Medicine and Rehabilitation, 82(3), 419–425. doi: 10.1053/apmr.2001.19778
  • McKay, M., Baldwin, J., Ferreira, P., Simic, M., Vanicek, N., & Burns, J. (2017). Normative reference values for strength and flexibility of 1,000 children and adults. Neurology, 88(1), 36–43. doi: 10.1212/WNL.0000000000003466
  • Molenaers, G., Fagard, K., Van Campenhout, A., & Desloovere, K. (2013). Botulinum toxin A treatment of the lower extremities in children with cerebral palsy. Journal of Children's Orthopaedics, 7(5), 383–387. doi: 10.1007/s11832-013-0511-x
  • Ostensjø, S., Carlberg, E., & Vøllestad, N. (2004). Motor impairments in young children with cerebral palsy: Relationship to gross motor function and everyday activities. Developmental Medicine and Child Neurology, 46(9), 580–589. doi: 10.1111/j.1469-8749.2004.tb01021.x
  • Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997). Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine and Child Neurology, 39(4), 214–223. doi: 10.1111/j.1469-8749.1997.tb07414.x
  • Park, E., Rha, D., Yoo, J., Kim, S., Chang, W., & Song, S. (2010). Short-term effects of combined serial casting and botulinum toxin injection for spastic equinus in ambulatory children with cerebral palsy. Yonsei Medical Journal, 51(4), 579–584. doi: 10.3349/ymj.2010.51.4.579
  • Preiss, R. A., Condie, D. N., Rowley, D. I., & Graham, H. K. (2003). The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy. The Journal of Bone and Joint Surgery.British Volume, 85(7), 943–948. doi: 10.1302/0301-620X.85B7.13967
  • Reddihough, D., King, J., Coleman, G., Fosang, A., McCoy, A., Thomason, P., & Graham, H. K. (2002). Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Developmental Medicine and Child Neurology, 44(12), 820–827. doi: 10.1111/j.1469-8749.2002.tb00772.x
  • Rosenbaum, P., Walter, S., Hanna, S., Palisano, R., Russell, D., Raina, P., … Galuppi, B. (2002). Prognosis for gross motor function in cerebral palsy: Creation of motor development curves. Jama, 288(11), 1357–1363. doi: 10.1001/jama.288.11.1357
  • Rosenbaum, P., & Stewart, D. (2004). The world health organization international classification of functioning, disability, and health: A model to guide clinical thinking, practice and research in the field of cerebral palsy. Seminars in Pediatric Neurology, 11(1), 5–10. doi: 10.1016/j.spen.2004.01.002
  • Russell, D. J., Avery, L. M., Rosenbaum, P. L., Raina, P. S., Walter, S. D., & Palisano, R. J. (2000). Improved scaling of the gross motor function measure for children with cerebral palsy: Evidence of reliability and validity. Physical Therapy, 80(9), 873–885.
  • Strobl, W., Theologis, T., Brunner, R., Kocer, S., Viehweger, E., Pascual-Pascual, I., & Placzek, R. (2015). Best clinical practice in botulinum toxin treatment for children with cerebral palsy. Toxins, 7(5), 1629–1648.
  • Thorpe, D., Dusing, S., & Moore, C. (2005). Repeatability of temporospatial gait measures in children using the GAITRite electronic walkway. Archives of Physical Medicine and Rehabilitation, 86(12), 2342–2346. doi: 10.1016/j.apmr.2005.07.301
  • Waters, E., Maher, E., Salmon, L., Reddihough, D., & Boyd, R. (2005). Development of a condition-specific measure of quality of life for children with cerebral palsy: Empirical thematic data reported by parents and children. Child: Care, Health and Development, 31(2), 127–135. doi: 10.1111/j.1365-2214.2004.00476.x
  • Waters, E., Davis, E., Mackinnon, A., Boyd, R., Graham, H. K., Kai Lo, S., … Reddihough, D. (2007). Psychometric properties of the quality of life questionnaire for children with CP. Developmental Medicine and Child Neurology, 49(1), 49–55. doi: 10.1111/j.1469-8749.2007.0126a.x
  • Waters, E., Davis, E., Boyd, E., Reddihough, D., Mackinnon, A., Graham, H., … Ravens-Sieberer, U. (2006). Cerebral palsy quality of life questionnaire for children (CP QOL-child) manual. Melbourne: Deakin University.
  • Wren, T. A. L., Rethlefsen, S., & Kay, R. (2005). Prevalence of specific gait abnormalities in children with cerebral palsy: Influence of cerebral palsy subtype, age, and previous surgery. Journal of Pediatric Orthopedics, 25(1), 79–83.
  • Yam, W. K. L., & Leung, M. S. M. (2006). Interrater reliability of modified ashworth scale and modified tardieu scale in children with spastic cerebral palsy. Journal of Child Neurology, 21(12), 1031–1035. doi: 10.1177/7010.2006.00222
  • Yap, R., Majnemer, A., Benaroch, T., & Cantin, M. (2010). Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy. Developmental Medicine and Child Neurology, 52(2), 186–193. doi: 10.1111/j.1469-8749.2009.03365.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.